The Fate of Altered Hepatocytic Foci as a Result of Treatment with Oxodipine, a Calcium Channel Blocker

Abraham Nyska, Trevor Waner, Alvaro Galiano, Baruch Klein

Research output: Contribution to journalArticlepeer-review

Abstract

Abstract: The dietary administration of the calcium channel blocker oxodipine to Fischer (F344) rats for 12 and 30 months resulted in increased incidence of altered hepatocytic foci (AHF). As the Environmental Protection Agency (EPA) regards AHF as potentially precancerous it is important to accumulate experimental evidence which may negate this theory. In the case of oxodipine we proved that with dosages close to maximum tolerated dose (MTD) for prolonged periods no hepatic neoplasms were produced. The possible nature of such AHF is discussed. 1992 Nordic Pharmacological Society

Original languageEnglish
Pages (from-to)439-442
Number of pages4
JournalBasic and Clinical Pharmacology and Toxicology
Volume70
Issue number6
DOIs
StatePublished - Jun 1992

Fingerprint

Dive into the research topics of 'The Fate of Altered Hepatocytic Foci as a Result of Treatment with Oxodipine, a Calcium Channel Blocker'. Together they form a unique fingerprint.

Cite this